AHE Price sensitive 29 Aug 2025, 9:47 AM

Appendix 4E Preliminary Final Report FY25

Adheris Health Ltd

MedAdvisor Reports FY25 Preliminary Results

Key points

  • Revenue down 36% to $62.9 million
  • Loss of $60.2 million, a 7700.9% decrease from prior year
  • Impairment of $46.5 million in assets

Full summary

MedAdvisor Limited has reported its preliminary financial results for the year ended 30 June 2025. The company's revenue declined 36% to $62.9 million, while it recorded a loss of $60.2 million, a 7700.9% decrease from the prior year's profit of $792,133. The loss was driven by a $46.5 million impairment of assets, primarily related to the company's US operations which faced significant challenges due to industry and regulatory changes. The company also reported a decline in net tangible assets per ordinary security from (2.40) cents to (0.26) cents. MedAdvisor did not pay, recommend or declare any dividends during the current or previous financial year.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in